These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 14999438)

  • 21. Assessment of cryopreserved hepatocytes as an alternative to fresh hepatocytes for comparative interspecies metabolism studies with suitable acceptance criteria.
    Cheng ZZ; Herron CE; Bowers G; de Serres M
    Drug Metab Lett; 2007 Apr; 1(2):109-20. PubMed ID: 19356029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucuronidation and sulfation of 7-hydroxycoumarin in liver matrices from human, dog, monkey, rat, and mouse.
    Wang Q; Jia R; Ye C; Garcia M; Li J; Hidalgo IJ
    In Vitro Cell Dev Biol Anim; 2005; 41(3-4):97-103. PubMed ID: 16029080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase I and phase II metabolite identification of rutaecarpine in freshly isolated hepatocytes from male Sprague-Dawley rats.
    Lee DW; Kang Y; Kang MJ; Noh K; Kim JH; Nepal MR; Shakya R; Lee YJ; Jahng Y; Lee S; Kim JA; Jeong TC
    Arch Pharm Res; 2017 Aug; 40(8):972-979. PubMed ID: 28799086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolism of MK-0524, a prostaglandin D2 receptor 1 antagonist, in microsomes and hepatocytes from preclinical species and humans.
    Dean BJ; Chang S; Silva Elipe MV; Xia YQ; Braun M; Soli E; Zhao Y; Franklin RB; Karanam B
    Drug Metab Dispos; 2007 Feb; 35(2):283-92. PubMed ID: 17132765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production.
    Ireson C; Orr S; Jones DJ; Verschoyle R; Lim CK; Luo JL; Howells L; Plummer S; Jukes R; Williams M; Steward WP; Gescher A
    Cancer Res; 2001 Feb; 61(3):1058-64. PubMed ID: 11221833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of fresh and cryopreserved hepatocytes as in vitro drug metabolism tools for the prediction of metabolic clearance.
    McGinnity DF; Soars MG; Urbanowicz RA; Riley RJ
    Drug Metab Dispos; 2004 Nov; 32(11):1247-53. PubMed ID: 15286053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigation of the in vitro metabolism profile of a phosphodiesterase-IV inhibitor, CDP-840: leading to structural optimization.
    Li C; Chauret N; Trimble LA; Nicoll-Griffith DA; Silva JM; MacDonald D; Perrier H; Yergey JA; Parton T; Alexander RP; Warrellow GJ
    Drug Metab Dispos; 2001 Mar; 29(3):232-41. PubMed ID: 11181489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of cryopreserved human hepatocytes as a model system to investigate sulfation and glucuronidation and to evaluate inhibitors of drug conjugation.
    Riches Z; Bloomer J; Patel A; Nolan A; Coughtrie M
    Xenobiotica; 2009 May; 39(5):374-81. PubMed ID: 19280384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of fulminant liver failure by transplantation of microencapsulated primary or immortalized xenogeneic hepatocytes.
    Mai G; Huy NT; Morel P; Mei J; Bosco D; Berney T; Majno P; Mentha G; Trono D; Buhler LH
    Transplant Proc; 2005; 37(1):527-9. PubMed ID: 15808699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human, rat, and mouse metabolism of resveratrol.
    Yu C; Shin YG; Chow A; Li Y; Kosmeder JW; Lee YS; Hirschelman WH; Pezzuto JM; Mehta RG; van Breemen RB
    Pharm Res; 2002 Dec; 19(12):1907-14. PubMed ID: 12523673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Verapamil hepatic clearance in four preclinical rat models: towards activity-based scaling.
    Nicolaï J; De Bruyn T; Van Veldhoven PP; Keemink J; Augustijns P; Annaert P
    Biopharm Drug Dispos; 2015 Oct; 36(7):462-80. PubMed ID: 25963583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interspecies variability in expression of hepatobiliary transporters across human, dog, monkey, and rat as determined by quantitative proteomics.
    Wang L; Prasad B; Salphati L; Chu X; Gupta A; Hop CE; Evers R; Unadkat JD
    Drug Metab Dispos; 2015 Mar; 43(3):367-74. PubMed ID: 25534768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired glutathione-conjugating capacity by cryopreserved human and rat hepatocytes.
    Sohlenius-Sternbeck AK; Schmidt S
    Xenobiotica; 2005 Jul; 35(7):727-36. PubMed ID: 16316931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retention of transporter activities in cryopreserved, isolated rat hepatocytes.
    Houle R; Raoul J; Lévesque JF; Pang KS; Nicoll-Griffith DA; Silva JM
    Drug Metab Dispos; 2003 Apr; 31(4):447-51. PubMed ID: 12642471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cryopreserved rat, dog and monkey hepatocytes: measurement of drug metabolizing enzymes in suspensions and cultures.
    Hewitt NJ; Utesch D
    Hum Exp Toxicol; 2004 Jun; 23(6):307-16. PubMed ID: 15301157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of genistein metabolism in rats and humans using liver microsomes and hepatocytes.
    Bursztyka J; Perdu E; Tulliez J; Debrauwer L; Delous G; Canlet C; De Sousa G; Rahmani R; Benfenati E; Cravedi JP
    Food Chem Toxicol; 2008 Mar; 46(3):939-48. PubMed ID: 18063284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Verapamil: identification of novel metabolites in cultures of primary human hepatocytes and human urine by LC-MS(n) and LC-NMR.
    Borlak J; Walles M; Elend M; Thum T; Preiss A; Levsen K
    Xenobiotica; 2003 Jun; 33(6):655-76. PubMed ID: 12851041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Species differences in the elimination of a peroxisome proliferator-activated receptor agonist highlighted by oxidative metabolism of its acyl glucuronide.
    Kochansky CJ; Xia YQ; Wang S; Cato B; Creighton M; Vincent SH; Franklin RB; Reed JR
    Drug Metab Dispos; 2005 Dec; 33(12):1894-904. PubMed ID: 16183782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a novel in vitro model to predict hepatic clearance using fresh, cryopreserved, and sandwich-cultured hepatocytes.
    Lau YY; Sapidou E; Cui X; White RE; Cheng KC
    Drug Metab Dispos; 2002 Dec; 30(12):1446-54. PubMed ID: 12433818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug metabolizing capacity of cryopreserved human, rat, and mouse liver parenchymal cells in suspension.
    Steinberg P; Fischer T; Kiulies S; Biefang K; Platt KL; Oesch F; Böttger T; Bulitta C; Kempf P; Hengstler J
    Drug Metab Dispos; 1999 Dec; 27(12):1415-22. PubMed ID: 10570022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.